Fluocinonide cream- Valeant

Drug Profile

Fluocinonide cream- Valeant

Alternative Names: Fluocinonide cream 0.1% - Valeant Pharmaceuticals International; Vanos

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medicis Pharmaceutical Corporation
  • Developer Valeant Pharmaceuticals International
  • Class Anti-inflammatories; Antiallergics; Glucocorticoids
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Plaque psoriasis; Skin disorders

Most Recent Events

  • 28 Feb 2006 Launched for Skin disorders in USA (Topical)
  • 01 Jul 2005 Launched for Plaque psoriasis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top